Cited by 404Cancer, Lipids, and MetabolismLipid metabolism and biosynthesisCancer, Hypoxia, and Metabolism

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer

Migita, Toshiro, Narita, Tadahito, Nomura, Kimie, Miyagi, Erika, Inazuka, Fumika, Matsuura, Masaaki, Ushijima, Masaru, Mashima, Tetsuo, Seimiya, Hiroyuki, Satoh, Yukitoshi, Okumura, Sakae, Nakagawa, Ken, Ishikawa, Yuichi·2008·Cancer Research

DOI 10.1158/0008-5472.can-08-1235

Open this paper in CoChat — free account

Abstract

Enhanced glucose and lipid metabolism is one of the most common properties of malignant cells. ATP citrate lyase (ACLY) is a key enzyme of de novo fatty acid synthesis responsible for generating cytosolic acetyl-CoA and oxaloacetate. To evaluate its role in lung cancer progression, we here analyzed ACLY expression in a subset of human lung adenocarcinoma cell lines and showed a relationship with the phosphatidyl-inositol-3 kinase–Akt pathway. The introduction of constitutively active Akt into cells enhanced the phosphorylation of ACLY, whereas dominant-negative Akt caused attenuation. In human lung adenocarcinoma samples, ACLY activity was found to be significantly higher than in normal lung tissue. Immunohistochemical analysis further showed phosphorylated ACLY overexpression in 162 tumors, well-correlating with stage, differentiation grade, and a poorer prognosis. Finally, to show the therapeutic potential and mechanism of ACLY inhibition for lung cancer treatment, we assessed the effect of RNA interference targeting ACLY on lipogenesis and cell proliferation in A549 cells. ACLY inhibition resulted in growth arrest in vitro and in vivo. Interestingly, increased intracellular lipids were found in ACLY knockdown cells, whereas de novo lipogenesis was inhibited. Supplementation of insulin could rescue the proliferative arrest elicited by ACLY inhibition; however, in contrast, fatty acid palmitate induced cell death. Taken together, these findings suggest that ACLY is involved in lung cancer pathogenesis associated with metabolic abnormality and might offer a novel therapeutic target. [Cancer Res 2008;68(20):8547–54]

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-08-1235

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
On the origin of cancer cells
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
PI3K/Akt signalling pathway and cancer
Vara, J. Á. F., Casado, E., de Castro, J., Cejas, P., Belda-Iniesta, C., & González-Barón, M. (2003) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.07.007 · Cited by 2,489
Glycolysis inhibition for anticancer treatment
Pelicano, H., Martin, D. S., Xu, R., & Huang, P. (2006) · Oncogene · doi:10.1038/sj.onc.1209597 · Cited by 1,546
Histological Typing of Lung and Pleural Tumours
Travis, W. D., Colby, T. V., CORRIN, B., Shimosato, Y., & Brambilla, E. M. (1999) · Springer eBooks · doi:10.1007/978-3-642-60049-4 · Cited by 1,534
Akt Stimulates Aerobic Glycolysis in Cancer Cells
Elstrom, R. L., Bauer, D. E., Buzzai, M., Karnauskas, R., Harris, M. H., Plas, D. R., Zhuang, H., Cinalli, R. M., Alavi, A., Rudin, C. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2904 · Cited by 1,454
Large-scale characterization of HeLa cell nuclear phosphoproteins
Beausoleil, S. A., Jedrychowski, M. P., Schwartz, D., Elias, J. E., Villén, J., Li, J., Cohn, M. A., Cantley, L. C., & Gygi, S. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404720101 · Cited by 1,376

Show all 45 references

Sorted by citations

The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926
Cellular Fatty Acid Metabolism and Cancer
Currie, E., Schulze, A., Zechner, R., Walther, T. C., & Farese, R. V. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.017 · Cited by 2,123
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., et al. (2012) · Nature · doi:10.1038/nature10602 · Cited by 1,791
AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress
Jeon, S.-M., Chandel, N. S., & Hay, N. (2012) · Nature · doi:10.1038/nature11066 · Cited by 1,132
Targeting Metabolism for Cancer Therapy
Luengo, A., Gui, D. Y., & Vander Heiden, M. G. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.08.028 · Cited by 971
Regulation and metabolic functions of mTORC1 and mTORC2
Szwed, A., Kim, E., & Jacinto, E. (2021) · Physiological Reviews · doi:10.1152/physrev.00026.2020 · Cited by 855
Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development
Baenke, F., Peck, B., Miess, H., & Schulze, A. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.011338 · Cited by 772
Lipid metabolism in cancer: New perspectives and emerging mechanisms
Broadfield, L. A., Pane, A. A., Talebi, A., Swinnen, J. V., & Fendt, S. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.04.013 · Cited by 793
Emerging roles of lipid metabolism in cancer metastasis
Luo, X., Cheng, C., Tan, Z., Li, N., Tang, M., Yang, L., & Cao, Y. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0646-3 · Cited by 688
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
Butler, L. M., Perone, Y., Dehairs, J., Lupien, L. E., de Laat, V., Talebi, A., Loda, M., Kinlaw, W. B., & Swinnen, J. V. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.013 · Cited by 589
A Role for the Krebs Cycle Intermediate Citrate in Metabolic Reprogramming in Innate Immunity and Inflammation
Williams, N. C., & O'Neill, L. A. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00141 · Cited by 599
Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation
Lee, J. V., Carrer, A., Shah, S., Snyder, N. W., Wei, S., Venneti, S., Worth, A. J., Yuan, Z.-F., Lim, H.-W., Liu, S., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.06.004 · Cited by 563
De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy
Mashima, T., Seimiya, H., & TSURUO, T. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605007 · Cited by 569
Self-citation
The emerging role and targetability of the TCA cycle in cancer metabolism
Anderson, N. M., Mucka, P., Kern, J. G., & Feng, H. (2017) · Protein & Cell · doi:10.1007/s13238-017-0451-1 · Cited by 586
ATP-Citrate Lyase: A Key Player in Cancer Metabolism
Zaidi, N., Swinnen, J. V., & Smans, K. A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4112 · Cited by 573
A two-way street: reciprocal regulation of metabolism and signalling
Wellen, K. E., & Thompson, C. B. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3305 · Cited by 528
Lipid metabolism in sickness and in health: Emerging regulators of lipotoxicity
Yoon, H., Shaw, J. L., Haigis, M. C., & Greka, A. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.027 · Cited by 538
Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression
Yang, E., Wang, X., Gong, Z., Yu, M., Wu, H., & Zhang, D. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00359-5 · Cited by 514
Lipid metabolism in cancer progression and therapeutic strategies
Fu, Y., Zou, T., Shen, X., Nelson, P. J., Li, J., Wu, C., Yang, J., Zheng, Y., Bruns, C. J., Zhao, Y., et al. (2020) · MedComm · doi:10.1002/mco2.27 · Cited by 428
ATP-citrate lyase controls a glucose-to-acetate metabolic switch
Zhao, S., Torres, A., Henry, R. A., Trefely, S., Wallace, M., Lee, J. V., Carrer, A., Sengupta, A., Campbell, S. L., Kuo, Y.-M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.069 · Cited by 394
Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth
Lin, R., Tao, R., Gao, X., Li, T., Zhou, X., Guan, K.-L., Xiong, Y., & Lei, Q.-Y. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.07.002 · Cited by 384
Acetyl-CoA metabolism in cancer
Guertin, D. A., & Wellen, K. E. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00543-5 · Cited by 303
The fat side of prostate cancer
Zadra, G., Photopoulos, C., & Loda, M. F. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.03.010 · Cited by 301
Metabolic reprogramming in cancer: Mechanisms and therapeutics
Nong, S., Han, X., Yu, X., Qian, Y., Wei, Y., Zhang, T., Tian, K., Shen, K., Yang, J., & Ma, X. (2023) · MedComm · doi:10.1002/mco2.218 · Cited by 313
Metabolic genes in cancer: Their roles in tumor progression and clinical implications
Furuta, E., Okuda, H., Kobayashi, A., & Watabe, K. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.01.005 · Cited by 285
Oncogenic PI3K and K-Ras stimulate de novo lipid synthesis through mTORC1 and SREBP
Ricoult, S. J. H., Yecies, J. L., Ben‐Sahra, I., & Manning, B. D. (2015) · Oncogene · doi:10.1038/onc.2015.179 · Cited by 288
Mitochondria Targeting as an Effective Strategy for Cancer Therapy
Ghosh, P., Vidal, C., Dey, S., & Li, Z. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093363 · Cited by 272
Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches
Wong, C. C., Qian, Y., & Yu, J. Q. (2017) · Oncogene · doi:10.1038/onc.2016.485 · Cited by 266
Metabolic adaptation in hypoxia and cancer
Paredes, F., Williams, H. C., & Martín, A. S. (2021) · Cancer Letters · doi:10.1016/j.canlet.2020.12.020 · Cited by 276
Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer
Liu, S., Zhang, X., Wang, W., Li, X., Sun, X., Zhao, Y., Wang, Q., Li, Y., Hu, F., & Ren, H. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02165-x · Cited by 300
ATP-citrate lyase: A mini-review
Chypre, M., Zaidi, N., & Smans, K. A. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.04.144 · Cited by 257
ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism
Granchi, C. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.09.001 · Cited by 251
ATP citrate lyase: A central metabolic enzyme in cancer
Icard, P., Wu, Z., Fournel, L., Coquerel, A., Lincet, H., & Alifano, M. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.12.010 · Cited by 247
Dysregulated lipid metabolism in cancer
Zhang, F. (2012) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v3.i8.167 · Cited by 241
ATP-citrate lyase (ACLY) in lipid metabolism and atherosclerosis: An updated review
Feng, X., Zhang, L., Xu, S., & Shen, A.-Z. (2019) · Progress in Lipid Research · doi:10.1016/j.plipres.2019.101006 · Cited by 242
ACLY facilitates colon cancer cell metastasis by CTNNB1
Wen, J., Min, X., Shen, M., Hua, Q., Han, Y., Zhao, L., Liu, L., Huang, G., Liu, J., & Zhao, X. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1391-9 · Cited by 231
Cancer Metabolism: Current Understanding and Therapies
Counihan, J. L., Grossman, E. A., & Nomura, D. K. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00775 · Cited by 236
Alterations of Lipid Metabolism in Cancer: Implications in Prognosis and Treatment
Fernández, L. P., de Cedrón, M. G., & de Molina, A. R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.577420 · Cited by 234
Metabolic Reprogramming by the PI3K-Akt-mTOR Pathway in Cancer
Lien, E. C., Lyssiotis, C. A., & Cantley, L. C. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-42118-6_3 · Cited by 217
Structure of ATP citrate lyase and the origin of citrate synthase in the Krebs cycle
Verschueren, K. H. G., Blanchet, C. E., Félix, J., Dansercoer, A., Vos, D. E. D., Bloch, Y., BEEUMEN, J. V., Svergun, D. I., Gutsche, I., Savvides, S. N., et al. (2019) · Nature · doi:10.1038/s41586-019-1095-5 · Cited by 205
Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer
Świerczyński, J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i9.2279 · Cited by 203
Metabolic rewiring in the promotion of cancer metastasis: mechanisms and therapeutic implications
Wei, Q., Qian, Y., Yu, J. Q., & Wong, C. C. (2020) · Oncogene · doi:10.1038/s41388-020-01432-7 · Cited by 193
Lipid metabolism and lung cancer
Salvador, M. M., de Cedrón, M. G., Moreno‐Rubio, J., Martínez, S. F., Sánchez‐Martínez, R., Casado, E., de Molina, A. R., & Sereno, M. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.02.001 · Cited by 185
Aberrant lipid metabolism as a therapeutic target in liver cancer
Pope, E. D., Kimbrough, E. O., Vemireddy, L. P., Surapaneni, P. K., Copland, J. A., & Mody, K. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1615883 · Cited by 186
Metabolic Signaling to the Nucleus in Cancer
Campbell, S. L., & Wellen, K. E. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.07.015 · Cited by 186
Acetyl-CoA Metabolism and Histone Acetylation in the Regulation of Aging and Lifespan
Bradshaw, P. C. (2021) · Antioxidants · doi:10.3390/antiox10040572 · Cited by 189
Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets
Tan, S. K., Hougen, H. Y., Merchan, J. R., Gonzalgo, M. L., & Welford, S. M. (2022) · Nature Reviews Urology · doi:10.1038/s41585-022-00654-6 · Cited by 181
Metabolic alterations and targeted therapies in prostate cancer
Flavin, R., Zadra, G., & Loda, M. F. (2010) · The Journal of Pathology · doi:10.1002/path.2809 · Cited by 178
miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer
Xin, M., Qiao, Z., Li, J., Liu, J., Song, S., Zhao, X., Miao, P., Tang, T., Wang, L., Liu, W., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10020 · Cited by 179
Altered cancer metabolism in mechanisms of immunotherapy resistance
Ramapriyan, R., Caetano, M. S., Barsoumian, H. B., Mafra, A. C. P., Zambalde, É. P., Menon, H., Tsouko, E., Welsh, J. W., & Cortez, M. A. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.004 · Cited by 173
The expanded role of fatty acid metabolism in cancer: new aspects and targets
Chen, M., & Huang, J. (2019) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbz017 · Cited by 172
Inhibition of lung cancer growth: ATP citrate lyase knockdown and statin treatment leads to dual blockade of mitogen‐activated protein Kinase (MAPK) and Phosphatidylinositol‐3‐kinase (PI3K)/AKT pathways
Hanai, J., Doro, N. C., Sasaki, A. T., Kobayashi, S. S., Cantley, L. C., Seth, P., & Sukhatme, V. P. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22895 · Cited by 170
The Lipogenesis Pathway as a Cancer Target
Abramson, H. N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2005805 · Cited by 167
Glucose-dependent de Novo Lipogenesis in B Lymphocytes
Dufort, F. J., Gumina, M. R., Ta, N. L., Tao, Y., Heyse, S. A., Scott, D. A., Richardson, A. D., Seyfried, T. N., & Chiles, T. C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.551051 · Cited by 160
Tumor Macroenvironment and Metabolism
Zoughbi, W. A., Huang, J., Paramasivan, G. S., Till, H., Pichler, M., Guertl‐Lackner, B., & Höefler, G. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.02.005 · Cited by 163
Stearoyl CoA desaturase-1: New insights into a central regulator of cancer metabolism
Igal, R. A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.09.009 · Cited by 166
Lipid metabolism alteration contributes to and maintains the properties of cancer stem cells
Li, H., Feng, Z., & He, M. (2020) · Theranostics · doi:10.7150/thno.41388 · Cited by 161
When fats commit crimes: fatty acid metabolism, cancer stemness and therapeutic resistance
Kuo, C., & Ann, D. K. (2018) · 癌症：英文版 · doi:10.1186/s40880-018-0317-9 · Cited by 153
Inactivation of ATP citrate lyase by Cucurbitacin B: A bioactive compound from cucumber, inhibits prostate cancer growth
Gao, Y., Islam, M. S., Tian, J., Lui, V. W. Y., & Xiao, D. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.03.015 · Cited by 144
The IKKβ‐USP30‐ACLY Axis Controls Lipogenesis and Tumorigenesis
Gu, L., Zhu, Y., Lin, X., Lu, B., Zhou, X., Zhou, F., Zhao, Q., Prochownik, E. V., & Li, Y. (2020) · Hepatology · doi:10.1002/hep.31249 · Cited by 147
Cullin3–KLHL25 ubiquitin ligase targets ACLY for degradation to inhibit lipid synthesis and tumor progressionPreprint
Zhang, C., Liu, J., Huang, G., Zhao, Y., Yue, X., Wu, H., Li, J., Zhu, J., Shen, Z., Haffty, B. G., et al. (2016) · Genes & Development · doi:10.1101/gad.283283.116 · Cited by 140
mTORC2 in the center of cancer metabolic reprogramming
Masui, K., Cavenee, W. K., & Mischel, P. S. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.04.002 · Cited by 140
Liverome: a curated database of liver cancer-related gene signatures with self-contained context information
Lee, L., Wang, K., Li, G., Zhi, X., Wang, Y., Xu, J., Sun, S., Pocalyko, D. J., Bhak, J., Kim, C., et al. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-s3-s3 · Cited by 134
Lipid pathway deregulation in advanced prostate cancer
Galbraith, L. C. A., Leung, H. Y., & Ahmad, I. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.022 · Cited by 130
Identification of ATP citrate lyase as a positive regulator of glycolytic function in glioblastomas
Beckner, M. E., Fellows-Mayle, W. K., Zhang, Z., Agostino, N. R., Kant, J. A., Day, B. W., & Pollack, I. F. (2009) · International Journal of Cancer · doi:10.1002/ijc.24918 · Cited by 127
Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets
Miranda‐Gonçalves, V., Lameirinhas, A., Henrique, R., & Jerónimo, C. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00427 · Cited by 125
Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance
Masui, K., Tanaka, K., Ikegami, S., Villa, G. R., Yang, H., Yong, W. H., Cloughesy, T. F., Yamagata, K., Arai, N., Cavenee, W. K., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511759112 · Cited by 123
An Epigenetic Role of Mitochondria in Cancer
Liu, Y., Chen, C., Wang, X., Sun, Y., Zhang, J., Chen, J., & Shi, Y. (2022) · Cells · doi:10.3390/cells11162518 · Cited by 131
Cancer Cells Differentially Activate and Thrive on De Novo Lipid Synthesis Pathways in a Low-Lipid Environment
Daniëls, V. W., Smans, K. A., Royaux, I. E., Chypre, M., Swinnen, J. V., & Zaidi, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106913 · Cited by 119
Targeting ATP-Citrate Lyase in Hyperlipidemia and Metabolic Disorders
Pinkosky, S. L., Groot, P. H. E., Lalwani, N. D., & Steinberg, G. R. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.09.001 · Cited by 118
ATP Citrate Lyase Knockdown Induces Growth Arrest and Apoptosis through Different Cell- and Environment-Dependent Mechanisms
Zaidi, N., Royaux, I. E., Swinnen, J. V., & Smans, K. A. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0095 · Cited by 118
ATP Citrate Lyase Mediates Resistance of Colorectal Cancer Cells to SN38
Zhou, Y., Bollu, L. R., Tozzi, F., Ye, X., Bhattacharya, R., Gao, G., Dupre, E., Xia, L., Lu, J., Fan, F., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0098 · Cited by 115
Key Molecules of Fatty Acid Metabolism in Gastric Cancer
Li, C., Zhang, L., Qiu, Z., Deng, W., & Wang, W. (2022) · Biomolecules · doi:10.3390/biom12050706 · Cited by 119
Metabolic changes associated with tumor metastasis, part 2: Mitochondria, lipid and amino acid metabolism
Porporato, P. E., Payen, V. L., Baselet, B., & Sonveaux, P. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2100-2 · Cited by 115
The role of FAK in tumor metabolism and therapy
Zhang, J., & Hochwald, S. N. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.12.003 · Cited by 104
Gene expression signature of human HepG2 cell line
Costantini, S., Bernardo, G. D., Cammarota, M., Castello, G., & Colonna, G. (2013) · Gene · doi:10.1016/j.gene.2012.12.106 · Cited by 93
ATP-citrate lyase: genetics, molecular biology and therapeutic target for dyslipidemia
Burke, A. C., & Huff, M. W. (2017) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000390 · Cited by 91
Identification of the Citrate-binding Site of Human ATP-Citrate Lyase Using X-ray Crystallography
Sun, T., Hayakawa, K., Bateman, K., & Fraser, M. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.078667 · Cited by 96
Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis
O’Brien, A. J., Villani, L. A., Broadfield, L. A., Houde, V. P., Galić, S., Blandino, G., Kemp, B. E., Tsakiridis, T. K., Muti, P. C., & Steinberg, G. R. (2015) · Biochemical Journal · doi:10.1042/bj20150122 · Cited by 90
MUC1: A novel metabolic master regulator
Mehla, K., & Singh, P. K. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.01.001 · Cited by 92
Retraction Note to: Decreased Warburg effect induced by ATP citrate lyase suppression inhibits tumor growth in pancreatic cancer
Zong, H., Zhang, Y., You, Y., Cai, T., & Wang, Y. (2015) · Medical Oncology · doi:10.1007/s12032-015-0685-9 · Cited by 90
Retracted
Cross-talk between HIF and p53 as mediators of molecular responses to physiological and genotoxic stresses
Obacz, J., Pastoreková, S., Vojtesek, B., & Hrstka, R. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-93 · Cited by 92
Reprogramming of Lipid Metabolism in Lung Cancer: An Overview with Focus on EGFR-Mutated Non-Small Cell Lung Cancer
Eltayeb, K., Monica, S. L., Tiseo, M., Alfieri, R. R., & Fumarola, C. (2022) · Cells · doi:10.3390/cells11030413 · Cited by 93
Cyclin E Associates with the Lipogenic Enzyme ATP-Citrate Lyase to Enable Malignant Growth of Breast Cancer Cells
Lucenay, K. S., Doostan, I., Karakaş, C., Bui, T. N., Ding, Z., Mills, G. B., Hunt, K. K., & Keyomarsi, K. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1646 · Cited by 92
The vital role of ATP citrate lyase in chronic diseases
Khwairakpam, A. D., Banik, K., Girisa, S., Shabnam, B., Shakibaei, M., Fan, L., Arfuso, F., Monisha, J., Wang, H., Mao, X., et al. (2019) · Journal of Molecular Medicine · doi:10.1007/s00109-019-01863-0 · Cited by 87
Key Roles of Glutamine Pathways in Reprogramming the Cancer Metabolism
Michalak, K. P., Maćkowska-Kędziora, A., Sobolewski, B., & Woźniak, P. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/964321 · Cited by 85
Oncogene-Driven Metabolic Alterations in Cancer
Min, H., & Lee, H. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.211 · Cited by 88
Histone acylation marks respond to metabolic perturbations and enable cellular adaptation
Jo, C., Park, S., Oh, S., Choi, J., Kim, E. K., Youn, H., & Cho, E. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00539-x · Cited by 86
PI3K signaling-regulated metabolic reprogramming: From mechanism to application
Su, W. Y., Tian, L. Y., Guo, L. P., Huang, L., & Gao, W. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188952 · Cited by 88
The GCN5: its biological functions and therapeutic potentials
Haque, M. E., Jakaria, M., Akther, M., Cho, D.-Y., Kim, I., & Choi, D. (2021) · Clinical Science · doi:10.1042/cs20200986 · Cited by 83
Polyunsaturated fatty acid metabolism in prostate cancer
Berquin, I. M., Edwards, I. J., Kridel, S. J., & Chen, Y. Q. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9299-7 · Cited by 81
Changes in Gene Transcription Underlying the Aberrant Citrate and Choline Metabolism in Human Prostate Cancer Samples
Bertilsson, H., Tessem, M., Flatberg, A., Viset, T., Gribbestad, I. S., Angelsen, A., & Halgunset, J. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2929 · Cited by 80
The Heterogeneity of Lipid Metabolism in Cancer
Park, J. K., Coffey, N. J., Limoges, A., & Le, A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-77736-8_3 · Cited by 80
Yeast and cancer cells – common principles in lipid metabolism
Natter, K., & Kohlwein, S. D. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.09.003 · Cited by 78
Repression of endometrial tumor growth by targeting SREBP1 and lipogenesis
Li, W., Tai, Y., Zhou, J., Gu, W., Bai, Z., Zhou, T., Zhong, Z., McCue, P. A., Sang, N., Ji, J., et al. (2012) · Cell Cycle · doi:10.4161/cc.20811 · Cited by 79
The diverse role of the PPARγ coactivator 1 family of transcriptional coactivators in cancer
Girnun, G. D. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.01.007 · Cited by 76
GCN5 acetyltransferase in cellular energetic and metabolic processes
Mutlu, B., & Puigserver, P. (2020) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2020.194626 · Cited by 82
Exploring the Role of ATP-Citrate Lyase in the Immune System
Dominguez, M., Brüne, B., & Namgaladze, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.632526 · Cited by 79
ATP-citrate lyase regulates stemness and metastasis in hepatocellular carcinoma via the Wnt/β-catenin signaling pathway
Han, Q., Chen, C.-A., Yang, W. K., Liang, D., Lv, H., Lv, G., Zong, Q.-N., & Wang, H. (2020) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2020.05.010 · Cited by 73
The BRG1 chromatin remodeling enzyme links cancer cell metabolism and proliferation
Wu, Q., Madany, P., Dobson, J. R., Schnabl, J. M., Sharma, S., Smith, T. C., van Wijnen, A. J., Stein, J. L., Lian, J. B., Stein, G. S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9505 · Cited by 76

Authors: Migita, T., Narita, T., Nomura, K., Miyagi, E., Inazuka, F., Matsuura, M., Ushijima, M., Mashima, T., Seimiya, H., Satoh, Y., Okumura, S., Nakagawa, K., & Ishikawa, Y.
Affiliations: 1Pathology and Divisions of
Zenyaku Kogyo (Japan) (JP)
2Cancer Genomics, The Cancer Institute,
3Bioinformatics Group, Genome Center,
4Division of Molecular Biotherapy, Cancer Chemotherapy Center,
The Cancer Institute Hospital (JP)
ORCID: Migita, Toshiro
Ushijima, Masaru
Mashima, Tetsuo
Seimiya, Hiroyuki
Satoh, Yukitoshi
Nakagawa, Ken
Ishikawa, Yuichi
Venue: Cancer Research
Publisher: American Association for Cancer Research (AACR)
Published: 2008-10-15
Volume: 68
Issue: 20
Pages: 8547-8554
ISSN: 0008-5472 (ISSN-L)
1538-7445
DOI: 10.1158/0008-5472.can-08-1235
OpenAlex: W2136765222
Cited by: 403
References: 45
Citations by year: 2026: 17 · 2025: 16 · 2024: 32 · 2023: 26 · 2022: 36 · 2021: 48 · 2020: 34 · 2019: 24 · 2018: 25 · 2017: 21 · 2016: 17 · 2015: 21 · 2014: 20 · 2013: 22 · 2012: 17
FWCI: 2.93
Type: journal article
Language: en
Open access: closed
Locations: Cancer Research (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Keywords: ATP citrate lyase, non-small cell lung cancer, lung adenocarcinoma, de novo lipogenesis, lipogenesis, Akt signaling, PI3K/Akt signaling, acetyl-CoA, cancer metabolism, RNA interference, insulin, palmitate, cell proliferation, prognostic factors, therapeutic target
MeSH terms: Adenocarcinoma, Animals, ATP Citrate (pro-S)-Lyase, Carcinoma, Non-Small-Cell Lung, Enzyme Activation, Humans, Lung Neoplasms, Phosphorylation, Prognosis, Cell Line, Tumor, Proto-Oncogene Proteins c-akt, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks